Le tecnologie assistive per la disabilita. Dall’assistenza protesica alla promozione delle abilita e dell’inclusione. Quale ruolo puo svolgere il disability manager?
AIRUS · 01.01.2023
DOI: 10.14668/qtimes_15307 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIRUS, erschienen am 01.01.2023. Verfasst von Andrea Fiorucci und 1 weiteren Autor:innen.
Abstract (Originalsprache)
To date, WHO estimates that more than one billion people need assistive technology, but that only 10% of them have access to it. The article aims to analyze the current model of territorial prosthetic assistance, highlighting all the epistemological-cultural and practical difficulties that the Local Health Authorities and the professionals involved in the process are forced to face. The Disability Manager can better organize the prescriptive process with the aim of improving the user-centred choice of the aid, avoiding its abandonment, controlling its psycho-educational impact on the person's life. The paper highlights the need to think about a shift of focus: from the device for the deficit to the tool to solicit new skills and promotes inclusion; from "aid" to cultural device for the promotion of biopsy-chosocial well-being.
Schlagwörter
Zitieren
APA
Fiorucci, A., & Rossini, G. (2023). Le tecnologie assistive per la disabilita. Dall’assistenza protesica alla promozione delle abilita e dell’inclusione. Quale ruolo puo svolgere il disability manager?. AIRUS. https://doi.org/10.14668/qtimes_15307
Vancouver
Fiorucci A, Rossini G. Le tecnologie assistive per la disabilita. Dall’assistenza protesica alla promozione delle abilita e dell’inclusione. Quale ruolo puo svolgere il disability manager?. AIRUS. 2023. doi:10.14668/qtimes_15307
BibTeX
@article{Fiorucci2023,
author = {Fiorucci, Andrea and Rossini, Giuseppe},
title = {Le tecnologie assistive per la disabilita. Dall’assistenza protesica alla promozione delle abilita e dell’inclusione. Quale ruolo puo svolgere il disability manager?},
journal = {AIRUS},
year = {2023},
doi = {10.14668/qtimes_15307}
}
EUVIMED